Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Eli Lilly (LLY.US) makes another move! Acquires Calytrix for up to $1.5 billion, betting on rare blood cancer therapies

Eli Lilly (LLY.US) makes another move! Acquires Calytrix for up to $1.5 billion, betting on rare blood cancer therapies

智通财经智通财经2026/11/16 13:22
Show original
According to Zhitong Finance APP, Eli Lilly (LLY.US) has agreed to acquire privately held Calytrix Bio Inc. in a deal valued at up to $1.5 billion. This is the latest move by Eli Lilly in its ongoing acquisitions and strategic investments in the fields of oncology and autoimmune diseases.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!